Hanseatic Management Services Inc Moderna, Inc. Transaction History

Hanseatic Management Services Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$101.21 - $166.61 $40,484 - $66,644	400 New	400 $47,000
Q4 2021 Feb 09, 2022	SELL	$225.82 - $368.51 $523,902 - $854,943	-2,320 Closed	0 $0
Q3 2021 Oct 05, 2021	SELL	$221.9 - $484.47 $356,593 - $778,543	-1,607 Reduced 40.92%	2,320 $893,000
Q2 2021 Jul 30, 2021	BUY	$129.91 - $234.98 $16,758 - $30,312	129 Added 3.4%	3,927 $923,000
Q1 2021 May 11, 2021	BUY	$109.18 - $185.98 $11,463 - $19,527	105 Added 2.84%	3,798 $497,000
Q4 2020 Jan 29, 2021	SELL	$65.74 - $169.86 $213,392 - $551,365	-3,246 Reduced 46.78%	3,693 $386,000
Q3 2020 Oct 29, 2020	BUY	$54.34 - $94.85 $8,042 - $14,037	148 Added 2.18%	6,939 $491,000
Q2 2020 Aug 10, 2020	BUY	$29.67 - $80.0 $201,488 - $543,280	6,791 New	6,791 $436,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.